Guideline for the diagnosis and management of hypertension in adults — 2016

Genevieve M. Gabb, Arduino Mangoni, Craig S. Anderson, Diane Cowley, John S. Dowden, Jonathan Golledge, Graeme J. Hankey, Faline S. Howes, Les Leckie, Vlado Perkovic, Markus Schlaich, Nicholas A. Zwar, Tanya L. Medley, Leonard Arnolda

Research output: Contribution to journalArticleResearchpeer-review

101 Citations (Scopus)

Abstract

The National Heart Foundation of Australia has updated the Guide to management of hypertension 2008: assessing and managing raised blood pressure in adults (updated December 2010). Main recommendations • For patients at low absolute cardiovascular disease risk with persistent blood pressure (BP)≥160/100mmHg, start antihypertensive therapy. • The decision to treat at lower BP levels should consider absolute cardiovascular disease risk and/or evidence of endorgan damage, together with accurate BP assessment. • For patients at moderate absolute cardiovascular disease risk with persistent systolic BP≥140mmHg and/or diastolic BP≥90mmHg, start antihypertensive therapy. • Treat patients with uncomplicated hypertension to a target BP of <140/90mmHg or lower if tolerated. Changes in management as a result of the guideline • Ambulatory and/or home BP monitoring should be offered if clinic BP is ≥140/90mmHg, as out-of-clinic BP is a stronger predictor of outcome. • In selected high cardiovascular risk populations, aiming for a target of <120mmHg systolic can improve cardiovascular outcomes. If targeting <120mmHg, close follow-up is recommended to identify treatment-related adverse effects including hypotension, syncope, electrolyte abnormalities and acute kidney injury. Why the changes have been made • A 2015 meta-analysis of patients with uncomplicated mild hypertension (systolic BP range, 140e159 mmHg) demonstrated that BP-lowering therapy is beneficial (reduced stroke, cardiovascular death and all-cause mortality). • A 2015 trial comparing lower with higher blood pressure targets in selected high cardiovascular risk populations found improved cardiovascular outcomes and reduced mortality, with an increase in some treatment-related adverse events.

Original languageEnglish
Pages (from-to)85-89
Number of pages5
JournalMedical Journal of Australia
Volume205
Issue number2
DOIs
Publication statusPublished - 18 Jul 2016
Externally publishedYes

Fingerprint

Guidelines
Blood Pressure
Hypertension
Ambulatory Blood Pressure Monitoring
Cardiovascular Diseases
Antihypertensive Agents
Therapeutics
Mortality
Syncope
Acute Kidney Injury
Hypotension
Electrolytes
Population
Meta-Analysis
Cause of Death
Myocardial Infarction

Cite this

Gabb, G. M., Mangoni, A., Anderson, C. S., Cowley, D., Dowden, J. S., Golledge, J., ... Arnolda, L. (2016). Guideline for the diagnosis and management of hypertension in adults — 2016. Medical Journal of Australia, 205(2), 85-89. https://doi.org/10.5694/mja16.00526
Gabb, Genevieve M. ; Mangoni, Arduino ; Anderson, Craig S. ; Cowley, Diane ; Dowden, John S. ; Golledge, Jonathan ; Hankey, Graeme J. ; Howes, Faline S. ; Leckie, Les ; Perkovic, Vlado ; Schlaich, Markus ; Zwar, Nicholas A. ; Medley, Tanya L. ; Arnolda, Leonard. / Guideline for the diagnosis and management of hypertension in adults — 2016. In: Medical Journal of Australia. 2016 ; Vol. 205, No. 2. pp. 85-89.
@article{7121c58853d44a0f83d6e5057ac55ef6,
title = "Guideline for the diagnosis and management of hypertension in adults — 2016",
abstract = "The National Heart Foundation of Australia has updated the Guide to management of hypertension 2008: assessing and managing raised blood pressure in adults (updated December 2010). Main recommendations • For patients at low absolute cardiovascular disease risk with persistent blood pressure (BP)≥160/100mmHg, start antihypertensive therapy. • The decision to treat at lower BP levels should consider absolute cardiovascular disease risk and/or evidence of endorgan damage, together with accurate BP assessment. • For patients at moderate absolute cardiovascular disease risk with persistent systolic BP≥140mmHg and/or diastolic BP≥90mmHg, start antihypertensive therapy. • Treat patients with uncomplicated hypertension to a target BP of <140/90mmHg or lower if tolerated. Changes in management as a result of the guideline • Ambulatory and/or home BP monitoring should be offered if clinic BP is ≥140/90mmHg, as out-of-clinic BP is a stronger predictor of outcome. • In selected high cardiovascular risk populations, aiming for a target of <120mmHg systolic can improve cardiovascular outcomes. If targeting <120mmHg, close follow-up is recommended to identify treatment-related adverse effects including hypotension, syncope, electrolyte abnormalities and acute kidney injury. Why the changes have been made • A 2015 meta-analysis of patients with uncomplicated mild hypertension (systolic BP range, 140e159 mmHg) demonstrated that BP-lowering therapy is beneficial (reduced stroke, cardiovascular death and all-cause mortality). • A 2015 trial comparing lower with higher blood pressure targets in selected high cardiovascular risk populations found improved cardiovascular outcomes and reduced mortality, with an increase in some treatment-related adverse events.",
author = "Gabb, {Genevieve M.} and Arduino Mangoni and Anderson, {Craig S.} and Diane Cowley and Dowden, {John S.} and Jonathan Golledge and Hankey, {Graeme J.} and Howes, {Faline S.} and Les Leckie and Vlado Perkovic and Markus Schlaich and Zwar, {Nicholas A.} and Medley, {Tanya L.} and Leonard Arnolda",
year = "2016",
month = "7",
day = "18",
doi = "10.5694/mja16.00526",
language = "English",
volume = "205",
pages = "85--89",
journal = "Medical Journal of Australia",
issn = "0025-729X",
publisher = "AUSTRALASIAN MED PUBL CO LTD",
number = "2",

}

Gabb, GM, Mangoni, A, Anderson, CS, Cowley, D, Dowden, JS, Golledge, J, Hankey, GJ, Howes, FS, Leckie, L, Perkovic, V, Schlaich, M, Zwar, NA, Medley, TL & Arnolda, L 2016, 'Guideline for the diagnosis and management of hypertension in adults — 2016' Medical Journal of Australia, vol. 205, no. 2, pp. 85-89. https://doi.org/10.5694/mja16.00526

Guideline for the diagnosis and management of hypertension in adults — 2016. / Gabb, Genevieve M.; Mangoni, Arduino; Anderson, Craig S.; Cowley, Diane; Dowden, John S.; Golledge, Jonathan; Hankey, Graeme J.; Howes, Faline S.; Leckie, Les; Perkovic, Vlado; Schlaich, Markus; Zwar, Nicholas A.; Medley, Tanya L.; Arnolda, Leonard.

In: Medical Journal of Australia, Vol. 205, No. 2, 18.07.2016, p. 85-89.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Guideline for the diagnosis and management of hypertension in adults — 2016

AU - Gabb, Genevieve M.

AU - Mangoni, Arduino

AU - Anderson, Craig S.

AU - Cowley, Diane

AU - Dowden, John S.

AU - Golledge, Jonathan

AU - Hankey, Graeme J.

AU - Howes, Faline S.

AU - Leckie, Les

AU - Perkovic, Vlado

AU - Schlaich, Markus

AU - Zwar, Nicholas A.

AU - Medley, Tanya L.

AU - Arnolda, Leonard

PY - 2016/7/18

Y1 - 2016/7/18

N2 - The National Heart Foundation of Australia has updated the Guide to management of hypertension 2008: assessing and managing raised blood pressure in adults (updated December 2010). Main recommendations • For patients at low absolute cardiovascular disease risk with persistent blood pressure (BP)≥160/100mmHg, start antihypertensive therapy. • The decision to treat at lower BP levels should consider absolute cardiovascular disease risk and/or evidence of endorgan damage, together with accurate BP assessment. • For patients at moderate absolute cardiovascular disease risk with persistent systolic BP≥140mmHg and/or diastolic BP≥90mmHg, start antihypertensive therapy. • Treat patients with uncomplicated hypertension to a target BP of <140/90mmHg or lower if tolerated. Changes in management as a result of the guideline • Ambulatory and/or home BP monitoring should be offered if clinic BP is ≥140/90mmHg, as out-of-clinic BP is a stronger predictor of outcome. • In selected high cardiovascular risk populations, aiming for a target of <120mmHg systolic can improve cardiovascular outcomes. If targeting <120mmHg, close follow-up is recommended to identify treatment-related adverse effects including hypotension, syncope, electrolyte abnormalities and acute kidney injury. Why the changes have been made • A 2015 meta-analysis of patients with uncomplicated mild hypertension (systolic BP range, 140e159 mmHg) demonstrated that BP-lowering therapy is beneficial (reduced stroke, cardiovascular death and all-cause mortality). • A 2015 trial comparing lower with higher blood pressure targets in selected high cardiovascular risk populations found improved cardiovascular outcomes and reduced mortality, with an increase in some treatment-related adverse events.

AB - The National Heart Foundation of Australia has updated the Guide to management of hypertension 2008: assessing and managing raised blood pressure in adults (updated December 2010). Main recommendations • For patients at low absolute cardiovascular disease risk with persistent blood pressure (BP)≥160/100mmHg, start antihypertensive therapy. • The decision to treat at lower BP levels should consider absolute cardiovascular disease risk and/or evidence of endorgan damage, together with accurate BP assessment. • For patients at moderate absolute cardiovascular disease risk with persistent systolic BP≥140mmHg and/or diastolic BP≥90mmHg, start antihypertensive therapy. • Treat patients with uncomplicated hypertension to a target BP of <140/90mmHg or lower if tolerated. Changes in management as a result of the guideline • Ambulatory and/or home BP monitoring should be offered if clinic BP is ≥140/90mmHg, as out-of-clinic BP is a stronger predictor of outcome. • In selected high cardiovascular risk populations, aiming for a target of <120mmHg systolic can improve cardiovascular outcomes. If targeting <120mmHg, close follow-up is recommended to identify treatment-related adverse effects including hypotension, syncope, electrolyte abnormalities and acute kidney injury. Why the changes have been made • A 2015 meta-analysis of patients with uncomplicated mild hypertension (systolic BP range, 140e159 mmHg) demonstrated that BP-lowering therapy is beneficial (reduced stroke, cardiovascular death and all-cause mortality). • A 2015 trial comparing lower with higher blood pressure targets in selected high cardiovascular risk populations found improved cardiovascular outcomes and reduced mortality, with an increase in some treatment-related adverse events.

UR - http://www.scopus.com/inward/record.url?scp=84978719336&partnerID=8YFLogxK

U2 - 10.5694/mja16.00526

DO - 10.5694/mja16.00526

M3 - Article

VL - 205

SP - 85

EP - 89

JO - Medical Journal of Australia

JF - Medical Journal of Australia

SN - 0025-729X

IS - 2

ER -

Gabb GM, Mangoni A, Anderson CS, Cowley D, Dowden JS, Golledge J et al. Guideline for the diagnosis and management of hypertension in adults — 2016. Medical Journal of Australia. 2016 Jul 18;205(2):85-89. https://doi.org/10.5694/mja16.00526